ICS 2012 Scientific Podium Poster Session S24 - LUTS Evaluation and Treatment

	Scientific Podium Poster Session S24
	Friday 19th October 2012
	13:00 - 14:30
	Lunch provided

13:30

#211 Correlation of overactive bladder symptom score, voiding diary and urodynamic parameters in patients with overactive bladder

Presenter: Miho Song

Song M¹, Chun J¹, Yoo D S², Han J³, Chung J Y⁴, Choo M S¹
1. Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, 2. 1Department of Urology, Eulji University Hospital, Eulji University College of Medicine, Daejeon, Korea, 3. 2Departments of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Yangsan, Korea, 4. Department of Urology, Inje University Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea

13:35

#212 Perceptions about female urinary incontinence in different racial and ethnic groups: a systematic review

Presenter: Nazema Siddiqui

Siddiqui N¹, Levin P¹, Ammarell N¹, Phadtare A¹, Pietrobon R¹
1. Duke University Medical Center

13:40

#213 Do lower urinary tract symptoms (LUTS) predispose the individuals to more admissions in Taiwanese women? – A preliminary report

Presenter: Ming-Ping Wu

Wu M¹, Hsu Y², Wang J³, Su T⁴
1. Div Urogynecology and Pelvic Floor Reconstruction, Dept Obstetetrics and Gynecology, Chi Mei Foundation Hospital, Tainan, Taiwan, 2. Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy and Science, Tainan, Taiwan, 3. Department of Medical Research, Chi Mei Foundation Hospital, Tainan, Taiwan, 4. Division of Urogynecology, Department of Obstetrics and Gynecology, McKay Memorial Hospital, Taipei, Taiwan

13:45

#214 Familiality of Lower Urinary Tract Symptom Disorders in Women

Presenter: Peggy Norton

Norton P¹, Allen-Brady K¹, Cannon-Albright L¹
1. University of Utah School of Medicine

13:50

#215 Are Women using long-term Containment Products for Urinary Incontinence Willing to Explore Further Treatment?

Presenter: Ian Ramsay

Scobie J¹, Agur K¹, Miheso J¹, Hair M², Agur W¹, Ramsay I³
1. NHS Ayrshire & Arran, UK, 2. University of West of Scotland, UK, 3. NHS Forth Valley, UK

13:55

#216 Validation of a new screening instrument for assessment of urinary incontinence in women: the Self-Assessment Leakage Circumstances Questionnaire (LCQ)

Presenter: Arnaud Fauconnier

Fauconnier A¹, Fritel X², Ballout El Maoula A¹, Varas C¹, Dompeyre P¹, Bader G¹
1. CHI Poissy-Saint Germain, Université Versailles Saint-Quentin, 2. CHU de Poitiers, Université de Poitiers

14:00

#217 The patients with ketamine-induced cystitis (KIC) have more severe lower urinary tract symptoms and smaller bladder capacity than the patients with Interstitial cystitis / Bladder Painful Syndrome (IC/BPS)

Presenter: Wei Chih Chen

Chen W C¹, Lee M H², Lee S P¹, Chen Y L¹, Wu H C², Lin H M¹, Liou W B¹
1. Department of Urology, Fong Yuan Hospital, Department of Health, Taiwan, Republic of China, 2. Central Taiwan university of Science and Technology

14:05

#218 Cost-effectiveness study of diagnostic tools for the evaluation of female with overactive bladder symptoms

Presenter: L López-Fando Lavalle

López-Fando Lavalle L¹, Jiménez Cidre M A¹, Esteban Fuertes M², Prieto Chaparro L³, Arlandis Guzman S⁴, Franco de Castro A⁵, Salinas Casado J⁶, Castro Diaz D⁷, Gutierrez Ruiz C⁸, Ifu G⁹
1. Department of Urology. Hospital Ramón y Cajal, Madrid, 2. Department of Urology. Hospital de Parapléjicos, Toledo, 3. Department of Urology. Hospital de Elche, Alicante, 4. Department of Urology. Hospital La Fe, Valencia, 5. Department of Urology. Hospital Clinic i Provincial, Barcelona, 6. Department of Urology. Hospital Clinico San Carlos, Madrid, 7. Department of Urology. Hospital Universitario de Canarias, Tenerife, 8. Department of Urology. Fundación Puigvert, Barcelona, 9. Group of Investigation in Functional Urology and Urodynamics

14:10

#219 Female expert voiders uroflowmetry and test -retest variation.

Presenter: Peter Rosier

Rosier P¹, Hogen Esch F²
1. Department of Urology University Medical Centre Utrecht, 2. SOMT, Amersfoort, The Netherlands

14:15

#220 Long-term follow-up of patients with nocturnal enuresis due to detrusor overactivity and nocturnal polyuria

Presenter: Ann-Sofie Goessaert

Goessaert A¹, Schoenaers B², Everaert K¹, Vande Walle J³
1. Urology, University Hospital Ghent, Belgium, 2. Ghent University, Belgium, 3. Pediatric Nephrology, University Hospital Ghent, Belgium

14:20

#221 Correlation of the ICIQ/UI-SF to urodynamic diagnosis in women with urinary incontinence

Presenter: Paulo Palma

Gebara De Grande Di Sessa R¹, Herrmann V¹, Zanettini Riccetto C L¹, Figueiredo Palma T¹, Palma P¹
1. State University of Campinas

14:25

#222 Efficacy of mirabegron in patients with overactive bladder (OAB): Pre-specified analysis of three randomised, double-blind, placebo-controlled, Phase III studies

Presenter: Sender Herschorn

Nitti V¹, Herschorn S², Khullar V³, Cambronero J⁴, Angulo J⁵, Blauwet M B⁶, Dorrepaal C⁷, Siddiqui E⁸, van Kerrebroeck P⁹, Martin N¹⁰
1. NYU Langone Medical Center, Department of Urology, New York, NY, USA, 2. University of Toronto, Division of Urology, Toronto, ON, Canada, 3. St Mary’s Hospital, Imperial College, Urogynaecology Department, London, UK, 4. Infanta Leonor Hospital, Department of Urology, Madrid, Spain, 5. Hospital Universitario De Getafe, Department of Urology, Madrid, Spain, 6. Astellas Pharma Global Development, Inc., Global Data Science – Biostatistics, Deerfield, IL, USA, 7. Astellas Pharma Global Development – EU, Global Medical Science – Urology, Leiderdorp, The Netherlands, 8. Astellas Pharma Europe Ltd, Staines, Middlesex, UK, 9. Department of Urology, Maastricht University Medical Center, The Netherlands, 10. Astellas Scientific and Medical Affairs Inc, Deerfield, IL, USA

Content Visitors (staff only)

International Continence Society

LUTS Evaluation and Treatment

Session Schedule

International Continence Society

LUTS Evaluation and Treatment

Session Schedule

Comments

Chat